Show results for
Refine by
Health Of Emergency Articles & Analysis
58 news found
These models are valuable tools in the research and development of vaccines and therapeutics against this emerging global health threat. Zika virus is an arbovirus belonging to the genus Flavivirus. ...
In the ever-evolving landscape of biomedical research and public health, CD Formulation has emerged as a crucial player, offering comprehensive antiserum preparation services. ...
Viruses, being the most abundant entities on our planet, play a pivotal role in shaping ecosystems and influencing the health of organisms, including humans. Traditional virology approaches involve isolating and culturing individual viruses, which often hinder a comprehensive view of the intricate viral communities existing in various environments. ...
Fabentech, a pharmaceutical-stage biotechnology company specialized in the development, production and marketing of polyclonal antibodies for responding to emergency situations and treating emerging infectious diseases, today announced that it has been chosen to be a part of the COUNTERACT European consortium that is aiming to develop medical countermeasures to ...
This project has been funded in whole or in part with Federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, under Contract No. 75A50122C00025. ...
An interview with the lead author from The American Journal of Sports Medicine, Effects of the New York State Concussion Management and Awareness Act (“Lystedt Law”) on Concussion-Related Emergency Health Care Utilization Among Adolescents, 2005-2015 (here). ...
Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing novel therapies for patients suffering from life threatening critical care conditions and community based health emergencies, announced today that the U.S. Food and Drug Administration (FDA) has granted its lead compound, ENA-001, Orphan Drug Designation for the treatment of Apnea of ...
(SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced receipt of approximately $16 million of international procurement orders for oral TPOXX® (tecovirimat) in August and early September, including an approximate $10 million order by the European Commission, through funds from the European ...
Amerigo Scientific provides high-quality and cost-effective medical device products worldwide to advance human health and address health emergencies. Nowadays human papillomavirus (HPV) infection has been recognized as the prerequisite for most anogenital malignancies accounting for more than 90% of cervical and anal cancers, thus making it ...
BFS is cost-efficient for short and long runs, and highly suitable to scale quickly in order to meet unexpected spikes in demand such as for a rapid response to population-scale health emergencies. Advancements developed by ApiJect for temperature management now enable BFS manufacturing of a vast array of sterile injectable drugs, including ultra-cold mRNA ...
Such sustained healing provides patients with renewed hope of limb preservation, while offering significant reductions in healthcare resource utilization with resultant health economic savings. Professor Andrew Boulton, past-President of the European Association for the Study of Diabetes and Professor of Medicine at the University of Manchester, UK and University of Miami, USA, ...
We are very pleased about this external validation from the FDA and we are looking forward to advancing zapnometinib towards full development in this indication, which is considered an emerging global health threat due to man-made environmental and climatic changes. ...
Thanks to this grant, awarded in the context of the first call for HERA projects (HERA is a new European authority dedicated to preparing and responding to health emergencies), Fab’entech will be able to accelerate the development of its clinical programme in order to provide, as rapidly as possible, its treatment against SARS-CoV-2. ...
Breakthrough imaging solution for liver health offers physicians an accurate, accessible and affordable way to manage emerging health crisis In recognition of Liver Awareness Month this October, Sonic Incytes Medical Corp. is pleased to showcase VelacurTM, the first handheld 3D liver health assessment solution, at the ...
Four-year agreement with Bill & Melinda Gates Foundation to discover and develop small molecule therapeutics with less susceptibility to variants and greater patient access than current approaches -- Exscientia to use leading AI platform and in-house drug expertise to discover and develop five phase 1-ready assets; Gates Foundation to contribute sector expertise in antivirals and global ...
NEW YORK and SAN JUAN, Puerto Rico, Sept. 1, 2021 /PRNewswire/ -- miR Scientific, LLC, a healthcare company focused on transforming global cancer management, the Governor of Puerto Rico, Pedro Pierluisi, and the Puerto Rico Health Insurance Administration ("ASES") join forces today to officially make September 1 "Prostate Cancer Prevention Day". ...
At first glance, the news that the federal public health emergency will remain in place through the remainder of 2021 might seem like a bad sign for hopes of quickly beating back COVID-19 and finally returning to normal. ...
“Fatty liver disease is an emerging health crisis that affects 1 in 4 people worldwide and, with FDA clearance of VelacurTM, we’re excited to offer health care practitioners a breakthrough, point of care ultrasound solution to address this ...
Organized by FederUnacoma, the Italian association of agricultural machinery manufacturers, the Bologna event - the first event for the agromechanical sector that takes place "physically" after the restrictions imposed by the Covid 19 emergency - will be the international showcase of the latest generation technologies applied to agriculture, and it will offer businesspeople from ...
This publication follows November’s announcement that baricitinib, first identified as a potential treatment by the BenevolentAI team in February, was granted Emergency Use Authorisation (EUA) by the U.S. Food and Drug Administration (FDA) for use in hospitalised COVID-19 patients who require supplemental oxygen or invasive mechanical ventilation. ...